SCOPUS 정보 검색 플랫폼

Journal of Neural Transmission

Volumn 115, Issue 4, 2008, Pages 575-577

Botulinum toxin drugs: Future developments

(1) Dressler, D a

a UNIVERSITY OF ROSTOCK (Germany)

Author keywords

Antigenicity; Botulinum toxin; Drug development; Drugs; Specific biological activity; Treatment strategies

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

ANTIGENICITY; ARTICLE; DRUG ACTIVITY; DRUG EFFICACY; DRUG FORMULATION; DRUG LABELING; DRUG MARKETING; DRUG SAFETY; DRUG STABILITY; HUMAN; HYPERHIDROSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BOTULINUM TOXINS; DRUG COMPOUNDING; DRUG DESIGN; HUMANS; NEUROMUSCULAR DISEASES;

EID: 42149192501 PISSN: 03009564 EISSN: 14351463 Source Type: Journal
DOI: 10.1007/s00702-007-0863-9 Document Type: Article

Times cited : (18)

References (8)

1
- 0037216403
- Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis
- D Dressler R Benecke 2003 Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis Eur Neurol 49 34 38
- (2003) Eur Neurol , vol.49 , pp. 34-38
- Dressler, D.¹ Benecke, R.²

2
- 9244247668
- Antibody-induced failure of botulinum toxin type B therapy in de novo patients
- D Dressler H Bigalke 2004 Antibody-induced failure of botulinum toxin type B therapy in de novo patients Eur Neurol 52 132 135
- (2004) Eur Neurol , vol.52 , pp. 132-135
- Dressler, D.¹ Bigalke, H.²

3
- 0007588785
- Botulinum toxin therapy: Risk factors for therapy failure
- Suppl 2
- D Dressler G Dirnberger 2000 Botulinum toxin therapy: risk factors for therapy failure Mov Disord 15 Suppl 2 51
- (2000) Mov Disord , vol.15 , pp. 51
- Dressler, D.¹ Dirnberger, G.²

4
- 33645107639
- Immunological aspects of Botox®, Dysport®, and NeuroBloc®/Myobloc®/MyoBloc™
- Suppl 1
- D Dressler M Hallett 2006 Immunological aspects of Botox®, Dysport®, and NeuroBloc®/Myobloc®/MyoBloc™ Eur J Neurol 13 Suppl 1 11 15
- (2006) Eur J Neurol , vol.13 , pp. 11-15
- Dressler, D.¹ Hallett, M.²

5
- 0037426445
- Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia
- J Jankovic KD Vuong J Ahsan 2003 Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia Neurology 60 1186 1188
- (2003) Neurology , vol.60 , pp. 1186-1188
- Jankovic, J.¹ Vuong, K.D.² Ahsan, J.³

6
- 27744451445
- Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin
- JC Lee K Yokota H Arimitsu HJ Hwang Y Sakaguchi J Cui K Takeshi T Watanabe T Ohyama K Oguma 2005 Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin Microbiology 151 3739 3747
- (2005) Microbiology , vol.151 , pp. 3739-3747
- Lee, J.C.¹ Yokota, K.² Arimitsu, H.³ Hwang, H.J.⁴ Sakaguchi, Y.⁵ Cui, J.⁶ Takeshi, K.⁷ Watanabe, T.⁸ Ohyama, T.⁹ Oguma, K.¹⁰

7
- 0004045029
- 2 Blackwell Science Malden, MA
- P Moore M Naumann 2003 Handbook of botulinum toxin treatment 2 Blackwell Science Malden, MA
- (2003) Handbook of Botulinum Toxin Treatment
- Moore, P.¹ Naumann, M.²

8
- 0018901429
- Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery
- AB Scott 1980 Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery J Pediatr Ophthalmol Strabismus 17 21 25
- (1980) J Pediatr Ophthalmol Strabismus , vol.17 , pp. 21-25
- Scott, A.B.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.